Clovis Oncology, FibroGen Are Key Biotech Names For Goldman Sachs By: Benzinga via Benzinga July 20, 2015 at 07:56 AM EDT In a report published Sunday, Goldman Sachs analyst Terence Flynn discussed the biotech space, noting the sector's most commonly ... Read More >> Related Stocks: Astellas Pharma Inc Astrazeneca Plc ADR Clovis Oncology Inc Fibrogen Inc CS